(Q33641577)

28 July 2017

1 reference

title

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety (English)

1 reference

inflammatory bowel diseases

28 July 2017

main subject

0 references

1 reference

Sandborn WJ

1 reference

28 July 2017

Hanauer SB

series ordinal

1 reference

28 July 2017

publication date

1 May 1999

1 reference

Inflammatory Bowel Diseases

28 July 2017

published in

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

119-133

1 reference

Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor .alpha. induced receptor aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

The tumor necrosis factor ligand and receptor families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Taming TNF: strategies to restrain this proinflammatory cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Treatment of ulcerative colitis with an engineered human anti-TNFalpha antibody CDP571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

Extracolonic malignancies in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199905000-00008

10.1097/00054725-199905000-00008

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference